Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1539)	2/6/2006 12:49:14 PM
From: Jibacoa	Read Replies (2) of 3722

CRGN Opened on an upgap today after reporting its 4thQ results and receiving an "upgrade" from PJ.<g> bigcharts.marketwatch.com The stock needs to close above its Nov.21 H of 4.75 before it can test its Oct.26 H at 5.20 bigcharts.marketwatch.com It still will have to close its August 10 downgap above the 5.55 level in order to test its August1 H at 6.61 <g> bigcharts.marketwatch.com The loss/shr was trimmed from $0.45 to $0.29 and revenues increased more than 900% (from 1M to 10.6M ) In the fourth quarter of 2005, 454 Life Sciences, a majority-owned subsidiary of CuraGen, recognized $7.3 million in revenue from sales of instrument systems and proprietary reagents, fee for service sales and royalties, as well as $0.9 million in grant revenue. biz.yahoo.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next